A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
Clinical trial NCT00002408 · COMPLETED
Trial details
- NCT number
- NCT00002408
- Sponsor
- Shaman Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.